PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer

Song Gao, Anqi Ge, Shouping Xu, +4

Journal of Experimental & Clinical Cancer Research

Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.

Shouping Xu, Shiyao Sui, Jinfeng Zhang, +8

PubMed

Breast Cancer MetastasisEpithelial-to-mesenchymal TransitionOncologyMedicineCancer Cell Biology +11

Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer

Xianyu Zhang, Weiwei Zhao, Wei Wei, +25

Clinical Cancer Research

Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer

Shouping Xu, Jinfeng Zhang, Shiyao Sui, +7

Tumor Biology

The long non-coding RNA <i>EPB41L4A-AS2</i> inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors

Shouping Xu, Peiyuan Wang, Zilong You, +6

Oncotarget

EngineeringBreast Cancer TissuesFavorable PrognosesGene Expression OmnibusCancer Biology +18

Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis

Xianyu Zhang, Dezhi Zhao, Yanling Yin, +17

npj Breast Cancer

LncRNA TINCR favors tumorigenesis via STAT3–TINCR–EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer

Qin Wang, Jiena Liu, Zilong You, +9

Cell Death and Disease

Expression and prognostic values of ARID family members in breast cancer

Jinfeng Zhang, Siyu Hou, Zilong You, +6

Aging

Tumor BiologyBreast OncologyEngineeringArid FamilyMedicine +13

Long noncoding RNA <i>FER1L4</i> acts as an oncogenic driver in human pan‐cancer

Zilong You, Anqi Ge, Da Pang, +2

Journal of Cellular Physiology

Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer

Shanshan Sun, Hao Wu, Xiaohong Wu, +10

Frontiers in Oncology